Frederick Finnegan

SVP of Sales and Marketing, CORNERSTONE THERAPEUTICS INC.

Companies

SAB Biotherapeutics, Inc.Chief Business Officer Oct 22, 2021 to Mar 18, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

SAB Biotherapeutics, Inc. SABS38,596 shares²$99.4K at $2.58Oct 22, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 22, 2021Granted 38,596 shares of SAB Biotherapeutics, Inc.²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSAB Biotherapeutics, Inc., Chief Business Officer
2
SEC EDGARSAB Biotherapeutics, Inc. shares after the filing of Oct 22, 2021